Strata Critical Medical, Inc. (SRTA) Tops Q1 EPS by 6c, reiterates guidance

Strata Critical Medical, Inc. (NASDAQ: SRTA) reported Q1 EPS of $0.03, $0.06 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $67.4 million versus the consensus estimate of $63.68 million.

GUIDANCE:

Strata Critical Medical, Inc. sees FY2026 revenue of $260-275 million, versus the consensus of $399.6 million.

For earnings history and earnings-related data on Strata Critical Medical, Inc. (SRTA) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Cohen & Steers and DLC acquire Virginia grocery shopping center
• Shein targets $26-27 billion valuation in Hong Kong IPO - report